Ajanta Pharma Ltd Half Yearly Results

Gross Sales

2,656.38

2,316.54

2,331.56

2,159.23

2,049.48

Excise Duty

0

0

0

0

0

Net Sales

2,656.38

2,316.54

2,331.56

2,159.23

2,049.48

Other Operating Income

0

0

0

0

0

Other Income

85.67

48.55

45.95

41.51

43.09

Total Income

2,742.05

2,365.09

2,377.51

2,200.74

2,092.57

Total Expenditure

1,977.2

1,698.56

1,690.04

1,559.26

1,477.51

PBIDT

764.85

666.53

687.47

641.48

615.06

Interest

8.65

13.98

6.75

4.02

3.19

PBDT

756.2

652.55

680.72

637.46

611.87

Depreciation

84.26

75.75

68.36

68.51

66.89

Minority Interest Before NP

0

0

0

0

0

Tax

151.8

156.81

155.49

164.42

157.64

Deferred Tax

4.61

-38.15

-5.38

-8.22

-16.08

Reported Profit After Tax

515.53

458.14

462.25

412.75

403.42

Minority Interest After NP

0

0

0

0

0

Net Profit after Minority Interest

515.53

458.14

462.25

412.75

403.42

Extra-ordinary Items

0

0

0

0

0

Adjusted Profit After Extra-ordinary item

515.53

458.14

462.25

412.75

403.42

EPS (Unit Curr.)

41.27

36.26

36.88

32.67

32.04

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

1,400

0

0

Equity

25.07

25.07

25.07

25.27

25.27

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

28.79

28.77

29.48

29.7

30.01

PBDTM(%)

-

-

-

-

-

PATM(%)

19.4

19.77

19.82

19.11

19.68